Trials / Completed
CompletedNCT06360510
Comparison of %5 Dextrose and Betamethasone Injections in Patients With Carpal Tunnel Syndrome
Comparison of the Effectiveness of Ultrasound-guided 5% Dextrose and Betamethasone Injections in Patients With Carpal Tunnel Syndrome.
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 30 (actual)
- Sponsor
- Gaziler Physical Medicine and Rehabilitation Education and Research Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The aim of the study is to compare the effectiveness of ultrasound-guided betamethasone and 5% dextrose injection, which is routinely applied in clinical practice, in patients with mild and moderate carpal tunnel syndrome (CTS).
Detailed description
It is planned as an observational, single-center clinical study.A total of 28 patients diagnosed with mild-moderate carpal tunnel syndrome who meet the inclusion criteria will be included in the study.Patients who had been experiencing trigger finger symptoms for at least three month and who presented to the Gaziler Physical Medicine and Rehabilitation Training and Research Hospital, affiliated with the Health Sciences University Faculty of Medicine. Patients will be divided into two groups. One group will receive 5% dextrose, the other group will receive 1 session of local injection by mixing Celeston chronodose \[1ml/3 mg betamethasone acetate+3,947 mg betamethasone disodium phosphate (equivalent to 3 mg betamethasone)\] and 1 ml 2% prilocaine. Evaluations will be made before injection, at weeks 4 and 12.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | %5 dextrose injection | hydrodissection with %5 dextrose |
| PROCEDURE | betamethasone injection | perineural betamethasone injection |
Timeline
- Start date
- 2023-05-05
- Primary completion
- 2024-05-05
- Completion
- 2024-05-05
- First posted
- 2024-04-11
- Last updated
- 2026-02-23
Locations
1 site across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT06360510. Inclusion in this directory is not an endorsement.